工程细菌驱动的生物混合微机器人通过唤起热致死来增强IL-2免疫疗法
Ping Li1, Qianying Li1, Lu Ding2
1State Key Laboratory of Food Science and Resources, School of Food Science and Technology, Nanchang University, Nanchang 330047, China.
ACS nano
|March 13, 2026
概括
这项研究引入了用于癌症免疫治疗的新型生物混合微机器人,增强了对瘤的Interleukin-2 (IL-2) 输送. 微机器人有效地重新编程瘤微环境,将冷瘤转化为响应性利基,提供强大的抗瘤免疫力.
科学领域:
- 生物医学工程 生物医学工程
- 癌症免疫疗法癌症免疫疗法
- 纳米技术 纳米技术
背景情况:
- 干白素-2 (IL-2) 免疫疗法对转移性癌症有希望,但面临毒性和瘤向性差等局限性.
- 现有的免疫疗法在低响应率和全身副作用方面扎.
研究的目的:
- 开发一个生物混合微机器人 (IL-2@Z/C/A) 用于向和增强的癌症免疫治疗.
- 通过改善药物输送和减少非目标效应,克服传统IL-2疗法的局限性.
主要方法:
- 通过使用IL-2变体分泌的Nissle 1917 (EcN) 工程设计了一种生物混合微机器人,该机器人被涂上了以热性伊米达酸框架-8 (ZIF-8) 的Nissle 1917 (EcN).
- 微机器人被光敏化剂和催化剂染色,旨在在酸性瘤微环境 (TME) 中释放载荷.
- 在B16F10黑色素瘤模型中研究了激素灭亡诱导,氧气生成和PD-L1阻塞的协同效应.
主要成果:
- ZIF-8外保护了细菌和货物,使瘤定位和控制释放在TME中.
- IL-2@Z/C/A诱导了热,免疫性细胞死亡和促炎性细胞因子的产生.
- catalase活性产生氧气,缓解瘤缺氧和免疫抑制,而IL-2释放逆转T细胞耗尽.
- 结合疗法通过重新编程免疫抑制性TME并引起强大的抗瘤免疫力,实现了近乎完整的瘤回归.
结论:
- 生物混合微机器人 (IL-2@Z/C/A) 为空间控制的癌症免疫治疗提供了一个新的策略.
- 这种方法有效地将免疫学上"冷"的瘤转化为响应的利基,突出了增强抗瘤反应的潜力.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K


